Decades of human spaceflight have highlighted unique challenges in managing health and medication in space, shedding light on high-stakes scenarios where timely medical intervention is crucial. At the same time, on Earth, there is a growing need for improved telehealth solutions to serve patients in remote or rural locations where access to healthcare is limited. Space medicine has developed robust telemedical protocols to ensure astronaut well-being, and these approaches have spurred developments in terrestrial healthcare. However, gaps remain—particularly in the integration of pharmaceutical care through digital means. Space missions, with astronauts or less experienced spacefarers, currently lack dedicated telepharmacy systems to oversee medication use and provide real-time drug management during missions. Similarly, on Earth, remote patients often receive piecemeal support (phone consultations, basic digital reminders) rather than a comprehensive pharmacy-led telecare solution. Against this backdrop, the authors identify an opportunity to translate space telehealth knowledge into civilian digital health innovations. Their project addresses the need for a structured, telepharmacy-focused platform that can support medication management and patient safety both on Earth and in future space endeavours, effectively merging terrestrial digital health advancements with lessons from space.

Home / Publications / Publication

Home / Publications / Publication

plataforma digital
Image reproduced from the article.

Publication type: Article Summary
Original title: Development of a Digital Platform: A Perspective to Advance Space Telepharmacy
Article publication date: January 2023
Source: IEEE – Open Journal of Engineering in Medicine and Biology
Author(s): Marlise A dos Santos, Juliana Herbert, Ilaria Cinelli (Member, IEEE), Jose Antonio L Burmann, Vinicius V Soares & Thais Russomano

What is the goal, target audience, and areas of digital health it addresses?
     The paper presents the development of a digital telepharmacy platform aimed at providing remote pharmaceutical care, drawing inspiration from expertise in space medicine. The objective is to leverage lessons from space telemedicine to enhance pharmacotherapeutic support for patients who are geographically distant or lack easy access to healthcare services. Telepharmacy focuses on remote pharmaceutical guidance and monitoring to improve medication adherence and early detection of health issues, ultimately contributing to better patient outcomes. The target audience includes healthcare professionals—particularly pharmacists—and patients requiring regular medication management in remote or underserved areas, as well as potential future space travellers (astronauts or space tourists) who may need medical support during missions. The work falls under the umbrella of digital health and telehealth, with a specific focus on telepharmacy as a novel domain bridging traditional healthcare and aerospace medicine.

What is the context?
     Decades of human spaceflight have highlighted unique challenges in managing health and medication in space, shedding light on high-stakes scenarios where timely medical intervention is crucial. At the same time, on Earth, there is a growing need for improved telehealth solutions to serve patients in remote or rural locations where access to healthcare is limited. Space medicine has developed robust telemedical protocols to ensure astronaut well-being, and these approaches have spurred developments in terrestrial healthcare. However, gaps remain—particularly in the integration of pharmaceutical care through digital means. Space missions, with astronauts or less experienced spacefarers, currently lack dedicated telepharmacy systems to oversee medication use and provide real-time drug management during missions. Similarly, on Earth, remote patients often receive piecemeal support (phone consultations, basic digital reminders) rather than a comprehensive pharmacy-led telecare solution. Against this backdrop, the authors identify an opportunity to translate space telehealth knowledge into civilian digital health innovations. Their project addresses the need for a structured, telepharmacy-focused platform that can support medication management and patient safety both on Earth and in future space endeavours, effectively merging terrestrial digital health advancements with lessons from space.

What are the current approaches?
     Conventional approaches to remote healthcare rely heavily on telemedicine for medical consultations and telemonitoring of vital signs, but telepharmacy services remain limited. Existing telepharmacy interventions often involve simple, decentralised tools—like medication reminder apps or ad-hoc pharmacist consultations via telephone—without a unified platform or advanced decision-support. Meanwhile, in the context of spaceflight, astronaut health management leverages telehealth techniques (including remote medical check-ups and ground-controlled interventions) but is primarily focused on immediate medical care rather than comprehensive pharmacy services. This means that although astronauts receive medical support, the systematic pharmaceutical care (such as routine medication reviews, adherence monitoring, or personalised drug guidance) is not yet fully implemented with digital tools during space missions. The current standard on Earth for pharmacy practice in remote care typically involves community healthcare workers or follow-up phone calls. Thus, before this study, no integrated digital telepharmacy platform existed that could seamlessly connect patients, pharmacists, and an intelligent support system. This novel approach aims to fill that gap, complementing existing telehealth practices with a dedicated, evidence-based telepharmacy solution.

What does innovation consist of? How is the impact of this technology assessed? Or How does technology support this innovation?
     The core innovation is a comprehensive telepharmacy platform that delivers both pharmaceutical teleconsultations and teleassistance (remote monitoring/support by pharmacists) through a user-friendly digital application. Developed over approximately one year, the platform’s architecture includes two main modules: a front-end interface (built with ReactJS) for patient and practitioner interaction, and a back-end system (using NodeJS and a MySQL database) to manage data and service logic. The platform implements standardized service protocols derived from best practices in space and remote medicine, and integrates artificial intelligence for clinical decision support. This AI component leverages validated clinical guidelines and patient-specific data to provide timely recommendations or alerts to pharmacists, facilitating swift, evidence-based responses to patient needs. Key features of the platform encompass video conferencing for remote consultations, patient and professional records management (appointments, medical histories, medication data), scheduling of follow-ups post-hospital discharge, digital form-filling for prescriptions and treatment plans, and strict compliance with data privacy regulations (ensuring confidentiality and security in line with GDPR standards).

     To evaluate the platform’s impact, the team conducted pilot validation studies in real-world settings. The platform was tested in two separate cohorts: (i) a post-hospitalization follow-up program involving 20 cardiac patients monitored over 30 days, and (ii) a mental health support program for 17 patients over a 60-day period. In each scenario, the effectiveness of the telepharmacy service was assessed by tracking key outcomes such as medication adherence rates, number of subsequent hospital readmissions, and user satisfaction, comparing these metrics against typical outcomes from standard care procedures.

What are the main results? What is the impact of these results? Or What are the results obtained? What are the main conclusions from these results? What is the future of this approach?
     The initial results are highly encouraging. In the cardiac patient group, the telepharmacy intervention achieved a medication adherence rate of 95%, and, over the ensuing nine months, there was a roughly 25% reduction in hospital readmissions compared to control patients receiving standard care. Notably, physicians accepted and implemented 71% of the pharmacists’ recommendations delivered via the platform, indicating strong trust and collaborative potential between remote pharmacists and in-person doctors. In the mental health cohort, 88% of patients showed clinical improvement in their symptoms after two months of using the telepharmacy service, and none required re-hospitalization during the follow-up period. Moreover, patient engagement with treatment improved substantially (the number of non-adherent patients was cut by around half, and fully adherent patients increased by 28%). Across both pilots, all responding participants reported being satisfied with the telepharmacy service, highlighting the convenience and added value of continuous remote pharmacist support.

     In conclusion, the study demonstrates that a digital telepharmacy platform can significantly enhance pharmaceutical care outside of traditional healthcare settings, boosting treatment adherence and reducing complications that lead to emergency visits or hospital admissions. While designed for terrestrial use, this platform illustrates how digital health solutions can be adapted to the context of space missions, potentially benefiting astronauts and space tourists by providing reliable, ground-supported medication management. The authors emphasize that the success of such technology must be coupled with continued human oversight and involvement — pharmacists and physicians working together through the platform to maintain a personalized, empathetic approach to care. For future perspectives, further research and development are recommended, including trials in more challenging and extended scenarios (potentially under conditions analogous to space environments) to refine the platform’s features and ensure its readiness for eventual use in actual space missions, thereby advancing the field of space telepharmacy.

Do you have an innovative idea in healthcare field?

Share it with us and see it come to life.
We will help bring your projects to life!

Newsletter

Receive the latest updates from the InovarSaúde portal.

República Portuguesa logo
logotipo SNS
SPMS logotipo

Follow Us

YouTube
LinkedIn

Co-funded by

PRR Logotipo
república Portuguesa logo
União Europeia Logo

Newsletter

Receive the latest updates from the InovarSaúde portal.

República Portuguesa logo
SNS Logo
SPMS Logo

Follow Us

Co-funded by

PRR Logotipo
República Portuguesa logo
União Europeia Logo

Home / Publications / Publication

plataforma digital
Image reproduced from the article.

Publication type: Article Summary
Original title: Development of a Digital Platform: A Perspective to Advance Space Telepharmacy
Article publication date: January 2023
Source: IEEE – Open Journal of Engineering in Medicine and Biology
Author(s): Marlise A dos Santos, Juliana Herbert, Ilaria Cinelli (Member, IEEE), Jose Antonio L Burmann, Vinicius V Soares & Thais Russomano

What is the goal, target audience, and areas of digital health it addresses?
     The paper presents the development of a digital telepharmacy platform aimed at providing remote pharmaceutical care, drawing inspiration from expertise in space medicine. The objective is to leverage lessons from space telemedicine to enhance pharmacotherapeutic support for patients who are geographically distant or lack easy access to healthcare services. Telepharmacy focuses on remote pharmaceutical guidance and monitoring to improve medication adherence and early detection of health issues, ultimately contributing to better patient outcomes. The target audience includes healthcare professionals—particularly pharmacists—and patients requiring regular medication management in remote or underserved areas, as well as potential future space travellers (astronauts or space tourists) who may need medical support during missions. The work falls under the umbrella of digital health and telehealth, with a specific focus on telepharmacy as a novel domain bridging traditional healthcare and aerospace medicine.

What is the context?
     Decades of human spaceflight have highlighted unique challenges in managing health and medication in space, shedding light on high-stakes scenarios where timely medical intervention is crucial. At the same time, on Earth, there is a growing need for improved telehealth solutions to serve patients in remote or rural locations where access to healthcare is limited. Space medicine has developed robust telemedical protocols to ensure astronaut well-being, and these approaches have spurred developments in terrestrial healthcare. However, gaps remain—particularly in the integration of pharmaceutical care through digital means. Space missions, with astronauts or less experienced spacefarers, currently lack dedicated telepharmacy systems to oversee medication use and provide real-time drug management during missions. Similarly, on Earth, remote patients often receive piecemeal support (phone consultations, basic digital reminders) rather than a comprehensive pharmacy-led telecare solution. Against this backdrop, the authors identify an opportunity to translate space telehealth knowledge into civilian digital health innovations. Their project addresses the need for a structured, telepharmacy-focused platform that can support medication management and patient safety both on Earth and in future space endeavours, effectively merging terrestrial digital health advancements with lessons from space.

What are the current approaches?
     Conventional approaches to remote healthcare rely heavily on telemedicine for medical consultations and telemonitoring of vital signs, but telepharmacy services remain limited. Existing telepharmacy interventions often involve simple, decentralised tools—like medication reminder apps or ad-hoc pharmacist consultations via telephone—without a unified platform or advanced decision-support. Meanwhile, in the context of spaceflight, astronaut health management leverages telehealth techniques (including remote medical check-ups and ground-controlled interventions) but is primarily focused on immediate medical care rather than comprehensive pharmacy services. This means that although astronauts receive medical support, the systematic pharmaceutical care (such as routine medication reviews, adherence monitoring, or personalised drug guidance) is not yet fully implemented with digital tools during space missions. The current standard on Earth for pharmacy practice in remote care typically involves community healthcare workers or follow-up phone calls. Thus, before this study, no integrated digital telepharmacy platform existed that could seamlessly connect patients, pharmacists, and an intelligent support system. This novel approach aims to fill that gap, complementing existing telehealth practices with a dedicated, evidence-based telepharmacy solution.

What does innovation consist of? How is the impact of this technology assessed? Or How does technology support this innovation?
     The core innovation is a comprehensive telepharmacy platform that delivers both pharmaceutical teleconsultations and teleassistance (remote monitoring/support by pharmacists) through a user-friendly digital application. Developed over approximately one year, the platform’s architecture includes two main modules: a front-end interface (built with ReactJS) for patient and practitioner interaction, and a back-end system (using NodeJS and a MySQL database) to manage data and service logic. The platform implements standardized service protocols derived from best practices in space and remote medicine, and integrates artificial intelligence for clinical decision support. This AI component leverages validated clinical guidelines and patient-specific data to provide timely recommendations or alerts to pharmacists, facilitating swift, evidence-based responses to patient needs. Key features of the platform encompass video conferencing for remote consultations, patient and professional records management (appointments, medical histories, medication data), scheduling of follow-ups post-hospital discharge, digital form-filling for prescriptions and treatment plans, and strict compliance with data privacy regulations (ensuring confidentiality and security in line with GDPR standards).

     To evaluate the platform’s impact, the team conducted pilot validation studies in real-world settings. The platform was tested in two separate cohorts: (i) a post-hospitalization follow-up program involving 20 cardiac patients monitored over 30 days, and (ii) a mental health support program for 17 patients over a 60-day period. In each scenario, the effectiveness of the telepharmacy service was assessed by tracking key outcomes such as medication adherence rates, number of subsequent hospital readmissions, and user satisfaction, comparing these metrics against typical outcomes from standard care procedures.

What are the main results? What is the impact of these results? Or What are the results obtained? What are the main conclusions from these results? What is the future of this approach?
     The initial results are highly encouraging. In the cardiac patient group, the telepharmacy intervention achieved a medication adherence rate of 95%, and, over the ensuing nine months, there was a roughly 25% reduction in hospital readmissions compared to control patients receiving standard care. Notably, physicians accepted and implemented 71% of the pharmacists’ recommendations delivered via the platform, indicating strong trust and collaborative potential between remote pharmacists and in-person doctors. In the mental health cohort, 88% of patients showed clinical improvement in their symptoms after two months of using the telepharmacy service, and none required re-hospitalization during the follow-up period. Moreover, patient engagement with treatment improved substantially (the number of non-adherent patients was cut by around half, and fully adherent patients increased by 28%). Across both pilots, all responding participants reported being satisfied with the telepharmacy service, highlighting the convenience and added value of continuous remote pharmacist support.

     In conclusion, the study demonstrates that a digital telepharmacy platform can significantly enhance pharmaceutical care outside of traditional healthcare settings, boosting treatment adherence and reducing complications that lead to emergency visits or hospital admissions. While designed for terrestrial use, this platform illustrates how digital health solutions can be adapted to the context of space missions, potentially benefiting astronauts and space tourists by providing reliable, ground-supported medication management. The authors emphasize that the success of such technology must be coupled with continued human oversight and involvement — pharmacists and physicians working together through the platform to maintain a personalized, empathetic approach to care. For future perspectives, further research and development are recommended, including trials in more challenging and extended scenarios (potentially under conditions analogous to space environments) to refine the platform’s features and ensure its readiness for eventual use in actual space missions, thereby advancing the field of space telepharmacy.

Cadeira de rodas

Autonomous Patient Mobility in a Hospital Environment

The internal transport of patients in healthcare institutions, although at first glance it may seem like a simple task, represents a complex, continuous, demanding and time-consuming logistical operation that cuts across all levels of the…

Read more
Voz em IA

The Future of Diagnostics: Speech and AI

Speech is a biomarker that reflects, in a sensitive way, the integrated functioning of several physiological systems, namely the nervous, respiratory, and muscular systems. This complexity makes it a promising resource for detecting changes associated…

Read more
Literatura sobre os cuidados de saúde no futuro

What Literature Reveals About Healthcare in the Future

The healthcare sector is undergoing rapid transformation driven by population aging, increasing complexity of care, and digital advancements, in a context that requires greater integration, sustainability and adaptation to new realities such as the European…

Read more
Perturbação do sono

A Digital Intervention for Insomnia in Oncology

Insomnia is a sleep disorder characterised by persistent difficulties in initiating sleep, maintaining sleep during the night, or achieving restful sleep. These difficulties arise even in the presence of adequate sleeping conditions and are often…

Read more
Sistema de telemonitorização remota

Digital Technology Revolutionising Post-cardiac Surgery

According to the World Health Organisation, cardiovascular disease remains the leading cause of death worldwide, responsible for around 17.9 million deaths a year. Its high prevalence is associated with unhealthy lifestyles characterised by poor diet,…

Read more
Sistema robótico autónomo INSIDE

Autonomous Robotics System for Autism Therapy

Autism spectrum disorder is a neurodevelopmental condition with significant clinical, social and economic repercussions throughout life. According to the World Health Organization, it is estimated to affect approximately 1 in 160 children worldwide. Its origin…

Read more
Enfermeira com um telefone

Mobile Application to Improve Workflows in Nursing Homes

Portugal has one of the highest aging populations in the world, placing increasing pressure on elderly care services, especially in nursing homes. Healthcare professionals in these facilities are often overwhelmed due to the increasing number…

Read more
troca de informações de saúde e interoperabilidade

New Era of Interoperability in Healthcare Systems

The growing use of electronic health records, digital diagnostic systems and remote monitoring technologies has led to a significant increase in the volume and complexity of health data. This increase intensifies the need for continuous,…

Read more
robótica colaborativa

Collaborative Robotics Improves Working Conditions

Workers face growing challenges in the industrial environment. Among the most critical are fatigue and inappropriate postures, often associated with repetitive tasks and working conditions that lack ergonomic suitability. These factors represent significant risks for…

Read more
Benefícios da Eletrônica Médica

Detection of Anxiety and Panic Attacks in Real Time

The growing number of people with anxiety disorders, along with increased awareness of mental health, drives the need for new technological tools that provide remote and continuous monitoring of anxiety and panic disorders. Thus, the…

Read more
tele-ecografia

A Novel Approach for Robotic-assisted Tele-echography

Currently, robotic systems for ultrasound diagnostic procedures fall into two main categories: portable robots that require manual positioning and fully autonomous robotic systems that independently control the ultrasound probe’s orientation and positioning. Portable robots rely…

Read more
Personalização e tecnologia na gestão da Diabetes

Personalization and Technology in Diabetes Management

IPDM has significant potential to improve diabetes management and drive health system reforms to become high-performing, effective, equitable, accessible, and sustainable. Evidence and good practices inspire health system transformation. Adopting person-centred approaches like co-creation and…

Read more
TEF-HEALTH Logo

SPMS Integrates the TEF-Health Initiative

SPMS participates in the TEF-Health initiative as a partner in a consortium composed of 51 entities from 9 European Union countries. This action is co-financed by the European Commission and has a duration of five…

Read more
Global Digital Health Partnership Logo

SPMS Represents Portugal as Vice-president of GDHP

The GDHP is an intergovernmental organization in the digital health sector that facilitates cooperation and collaboration between government representatives and the World Health Organization (WHO). Its purpose is to foster policymaking that promote the digitalization…

Read more
Portugal INCoDe.2030

Digital Transformation of Health at INCoDe.2030 in Tomar

The “National Digital Skills Initiative e.2030, Portugal” (INCoDe.2030) is an initiative that aims to improve the Portuguese population’s level of digital skills, placing Portugal at the level of the most advanced European countries in this…

Read more
HealthData@PT Logo

HealthData@PT: New SPMS Initiative for Health Data

Action HealthData@PT is launched in the context of the implementation of the European Health Data Space, and is an initiative approved by the European Commission under the EU4Health 2021-2027 programme. This initiative contributes to the…

Read more

Do you have an innovative idea in healthcare field?

Share it with us and see it come to life.
We will help bring your projects to life!

Newsletter

Receive the latest updates from the Inovarsaúde portal.

República Portuguesa logo
SNS Logo
SPMS Logo

Follow Us

YouTube
LinkedIn

Co-funded by

PRR Logotipo
República Portuguesa logo
União Europeia Logo
Scroll to Top